KR

Kiran Rani Jindal

Director Director DIN 00377510
DIN 00377510 First appointment Jul 2004 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jul 2004
Shareholding value Locked Premium profile

About Kiran Rani Jindal

Data last updated:

Kiran Rani Jindal has 22 years in corporate governance. Formerly with 1 company, such as Skytech Pharma Private Limited. Engaged in Technology. Contributes to corporate operations.

DIN 00377510
Primary Designation Director
First Appointment 01 Jul 2004
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Skytech Pharma Private Limited U24233DL2004PTC127312
Director01 Jul 20042004Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Skytech Pharma Private Limited
Premium access

Shareholding and investment profile for Kiran Rani Jindal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kiran Rani Jindal

Kiran Rani Jindal has 22 years in corporate governance. Formerly with 1 company, such as Skytech Pharma Private Limited. Engaged in Technology. Contributes to corporate operations.

Kiran Rani Jindal is associated with 0 companies as a director.

Kiran Rani Jindal has expertise in Technology.

Kiran Rani Jindal has 22 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available